To Our New Jersey Life Sciences Community:
Welcome to another edition of the Weekender.
Exciting news this week for the State of New Jersey. The Board of the New Jersey Economic Development Authority approved Grow New Jersey (Grow NJ) tax credits for Macrocure, Inc., which is developing a platform to address chronic and hard-to-heal wounds, and Polaris Solutions, LLC, which provides compliance solutions for global pharmaceutical, medical device and life sciences companies. The addition of these companies to our ecosystem will not only support our community, it will create new jobs and help to ensure that life-saving therapies and drugs continue to be developed for the Patients who need them.
BioNJ Member Merck and MD Anderson Cancer Center, with locations at Cooper Medical Center in Camden and the University of Texas, have entered into a clinical research partnership to evaluate Merck’s immuno-oncology therapy options with the goal to accelerate the delivery of new cancer treatments. As we say at BioNJ, “Because Patients Can’t Wait.”
Congratulations to BioNJ Chairman Stuart Peltz, Ph.D. and the Team at PTC Therapeutics on their fundraising announcement this week.
We officially launched the Third Annual CEO Summit this week with a dynamic roster of speakers and twenty-one sponsors. See additional information below. We hope you’ll join us.
Click here for this week’s Weekender.